A new subtype of differentiated #thyroid carcinomas that are therapeutically targetable from your friends @mghpathology #EndoPath #MolPath #MolDx #ThyroidCancer Tweet added by Peter Sadow, MD, PhD @PathDocBoston

Peter Sadow, MD, PhD

4 years

A new subtype of differentiated #thyroid carcinomas that are therapeutically targetable from your friends @mghpathology #EndoPath #MolPath #MolDx #ThyroidCancer

9

37

120

Israa Laklouk, MD, FCAP

@israalaklouk

4 years

@PathDocBoston @MGHPathology Congrats 👏

1

0

1

Peter Sadow, MD, PhD

@PathDocBoston

4 years

@israalaklouk @MGHPathology You’re next, doctor!

0

1

Daniel Berney

@daniel_berney

4 years

@PathDocBoston @MGHPathology Thank you for this Peter, I was just coming to grips with this myself in diagnostic terms so really helpful. Congratulations.

3

0

Peter Sadow, MD, PhD

@PathDocBoston

4 years

@daniel_berney @MGHPathology It’s my pleasure, Dan! I’m particularly proud of this one, as it seems to be fairly practical for pathologists with clinical applications, so figure 1 is a really good summary and the flow chart may be useful, too. Thank you so much for the positive feedback!

0

1

Jake Bledsoe

@jake_bledsoe

4 years

@PathDocBoston @MGHPathology Nice work.

1

0

2

Peter Sadow, MD, PhD

@PathDocBoston

4 years

@jake_bledsoe @MGHPathology Thanks, Jake!

0

Laura J. Tafe, MD

@LJTafeMD

4 years

@PathDocBoston @MGHPathology This is great! We recently had a TPR-NTRK1 case.

1

0

1

Peter Sadow, MD, PhD

@PathDocBoston

4 years

@LJTafeMD @MGHPathology I love them!! They are treatable!

1

0

1

Ritu Nayar, MD

@NayarRitu

4 years

@PathDocBoston @MGHPathology Great work. Thank you MGH team @PathDocBoston @bfaquin

1

0

2

Peter Sadow, MD, PhD

@PathDocBoston

4 years

@NayarRitu @MGHPathology @bfaquin Thank you so much! This study was such a joy to do with an extraordinarily hard-working #ENTPath #EndoPath fellow who truly steered the ship! Ying-Hsia was a powerhouse/force of nature!

0

2